These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice. Kelder B; Berryman DE; Clark R; Li A; List EO; Kopchick JJ Growth Horm IGF Res; 2007 Aug; 17(4):346-51. PubMed ID: 17544797 [TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth. McNeil CJ; Nwagwu MO; Finch AM; Page KR; Thain A; McArdle HJ; Ashworth CJ Reproduction; 2007 Mar; 133(3):653-61. PubMed ID: 17379659 [TBL] [Abstract][Full Text] [Related]
25. An ERRbeta/gamma agonist modulates GRalpha expression, and glucocorticoid responsive gene expression in skeletal muscle cells. Wang SC; Myers S; Dooms C; Capon R; Muscat GE Mol Cell Endocrinol; 2010 Feb; 315(1-2):146-52. PubMed ID: 19631715 [TBL] [Abstract][Full Text] [Related]
26. Coordinated regulation of the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus mykiss). Gabillard JC; Kamangar BB; Montserrat N J Endocrinol; 2006 Oct; 191(1):15-24. PubMed ID: 17065385 [TBL] [Abstract][Full Text] [Related]
27. Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients. Morgan SA; Berryman DE; List EO; Lavery GG; Stewart PM; Kopchick JJ Growth Horm IGF Res; 2022 Feb; 62():101440. PubMed ID: 34814007 [TBL] [Abstract][Full Text] [Related]
28. Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice. Alba M; Fintini D; Salvatori R Growth Horm IGF Res; 2005 Aug; 15(4):275-82. PubMed ID: 15979916 [TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy. Shavlakadze T; White JD; Davies M; Hoh JF; Grounds MD Neuromuscul Disord; 2005 Feb; 15(2):139-46. PubMed ID: 15694135 [TBL] [Abstract][Full Text] [Related]
30. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation. Lincoln DT; Singal PK; Al-Banaw A Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592 [TBL] [Abstract][Full Text] [Related]
31. Skeletal muscle 11βHSD1 activity of nondiabetic subjects is unaltered in central obesity-associated insulin resistance. Inder WJ; Obeyesekere VR; Alford FP; Jang C Horm Metab Res; 2011 Apr; 43(4):257-60. PubMed ID: 21249616 [TBL] [Abstract][Full Text] [Related]
32. Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Whorwood CB; Donovan SJ; Wood PJ; Phillips DI J Clin Endocrinol Metab; 2001 May; 86(5):2296-308. PubMed ID: 11344242 [TBL] [Abstract][Full Text] [Related]
33. Regulation of growth hormone receptors in human prostate cancer cell lines. Bidosee M; Karry R; Weiss-Messer E; Barkey RJ Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305 [TBL] [Abstract][Full Text] [Related]
34. Effect of genotype-nutrition interaction on growth and somatotropic gene expression in the chicken. Zhao R; Muehlbauer E; Decuypere E; Grossmann R Gen Comp Endocrinol; 2004 Mar; 136(1):2-11. PubMed ID: 14980790 [TBL] [Abstract][Full Text] [Related]
35. Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells. Frost RA; Lang CH Minerva Endocrinol; 2003 Mar; 28(1):53-73. PubMed ID: 12621363 [TBL] [Abstract][Full Text] [Related]
36. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029 [TBL] [Abstract][Full Text] [Related]
37. The role of 11beta-hydroxysteroid dehydrogenases in the brain. Holmes MC; Seckl JR Mol Cell Endocrinol; 2006 Mar; 248(1-2):9-14. PubMed ID: 16413106 [TBL] [Abstract][Full Text] [Related]
38. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis. Luque RM; Gahete MD; Valentine RJ; Kineman RD J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921 [TBL] [Abstract][Full Text] [Related]
39. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Gagliardi AD; Kuo EY; Raulic S; Wagner GF; DiMattia GE Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E92-105. PubMed ID: 15367391 [TBL] [Abstract][Full Text] [Related]
40. Expression of glucocorticoid receptor, mineralocorticoid receptor, and 11beta-hydroxysteroid dehydrogenase 1 and 2 in the fetal and postnatal ovine hippocampus: ontogeny and effects of prenatal glucocorticoid exposure. Sloboda DM; Moss TJ; Li S; Matthews SG; Challis JR; Newnham JP J Endocrinol; 2008 May; 197(2):213-20. PubMed ID: 18434351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]